Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
SDGR	SCHRODINGER INC	$854.89M	-29.50%	-14.70%	-19.05%	-25.60%	1.00	2.75	55.70%	-40.40%	-39.99%
TLRY	TILRAY BRANDS INC	$763.39M	-86.90%	-64.60%	-79.57%	-129.40%	0.35	2.79	27.70%	-156.70%	-168.48%
ATYR	ATYR PHARMA INC	$83.05M	-99.60%	-74.40%	-95.20%	-88.00%	0.38	5.30	100.00%	-39,009.50%	-39,009.47%
LXEO	LEXEO THERAPEUTICS INC	$423.78M	-67.30%	-56.00%	-39.65%	-84.80%	0.09	11.21	N/A	N/A	N/A
IVF	INVO FERTILITY INC	$949.43k	-475.60%	-100.40%	-293.09%	-7,843.00%	2.22	0.12	39.20%	-420.60%	-404.68%
SXTP	60 DEGREES PHARMACEUTICALS INC	$4.90M	-217.80%	-141.50%	-208.81%	-821.20%	0.57	2.66	35.70%	-1,252.60%	-1,172.67%
IRD	OPUS GENETICS INC	$323.73M	-452.30%	-114.50%	-116.49%	352.20%	2.27	6.43	100.00%	-349.30%	-348.42%
DSGN	DESIGN THERAPEUTICS INC	$692.58M	-32.70%	-31.10%	-32.74%	-35.10%	0.06	17.14	N/A	N/A	N/A
MDGL	MADRIGAL PHARMACEUTICALS INC	$12.55B	-43.80%	-24.90%	-28.02%	-29.60%	1.09	4.02	94.10%	-30.10%	-27.75%
CTEV	CLARITEV CORP	$289.01M	N/A	-5.70%	0.41%	0.40%	-29.07	0.86	73.80%	-29.40%	1.96%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$6.04M	-71.70%	-66.30%	-90.53%	-338.40%	0.11	9.79	100.00%	-43,832.50%	-43,732.65%
MIST	MILESTONE PHARMACEUTICALS INC	$162.38M	-656.80%	-81.20%	-59.47%	-83.40%	1.72	8.01	100.00%	-4,078.80%	-3,830.53%
MNKD	MANNKIND CORP	$770.25M	-11.20%	1.10%	6.35%	6.50%	-16.53	1.71	74.80%	1.70%	11.30%
PRE	PRENETICS GLOBAL LTD	$315.56M	-36.00%	-29.00%	-33.14%	-44.30%	0.17	3.01	53.00%	-63.10%	-63.08%
RLMD	RELMADA THERAPEUTICS INC	$733.18M	-170.80%	-145.60%	-65.53%	-178.90%	0.09	14.62	N/A	N/A	N/A
INTS	INTENSITY THERAPEUTICS INC	$14.48M	-214.80%	-148.80%	-97.08%	-22,212.40%	0.19	5.92	N/A	N/A	N/A
ELTX	ELICIO THERAPEUTICS INC	$195.92M	-977.70%	-141.60%	-216.53%	-335.50%	14.81	2.38	N/A	N/A	N/A
OKYO	OKYO PHARMA LTD	$64.60M	N/A	-123.50%	183.14%	79.90%	-2.36	0.58	N/A	N/A	N/A
PTCT	PTC THERAPEUTICS INC	$5.61B	-362.40%	25.20%	43.97%	88.70%	-15.12	2.35	97.30%	39.40%	49.05%
ENGN	ENGENE HOLDINGS INC	$448.16M	-55.80%	-45.70%	-38.23%	-51.90%	0.20	11.75	N/A	N/A	N/A
PLSE	PULSE BIOSCIENCES INC	$1.56B	-73.50%	-63.70%	-84.03%	-750.30%	0.17	10.53	-54.00%	-20,794.60%	-20,794.57%
EVO	EVOTEC SE	$920.33M	-18.10%	-8.50%	-8.37%	-8.40%	1.22	2.12	10.80%	-21.00%	-15.47%
HRTX	HERON THERAPEUTICS INC	$150.64M	N/A	-8.30%	-7.85%	-5.20%	16.85	2.48	73.30%	-13.00%	-8.09%
TLSI	TRISALUS LIFE SCIENCES INC	$259.94M	N/A	-196.70%	-141.31%	-89.20%	-2.04	2.80	84.60%	-154.30%	-74.59%
MXCT	MAXCYTE INC	$80.15M	-24.10%	-20.60%	-23.71%	-22.30%	0.18	8.30	81.20%	-135.10%	-135.14%
SI	SHOULDER INNOVATIONS INC	$301.45M	-106.90%	-33.40%	-25.87%	-42.70%	0.21	11.07	76.50%	-85.30%	-85.15%
MGNX	MACROGENICS INC	$195.12M	-120.20%	-29.90%	-31.25%	-35.10%	3.62	5.10	75.90%	-49.90%	-44.67%
BIOA	BIOAGE LABS INC	$776.65M	-27.90%	-25.50%	-29.08%	-98.60%	0.08	14.24	100.00%	-896.10%	-888.36%
ORIC	ORIC PHARMACEUTICALS INC	$892.18M	-38.80%	-36.20%	-33.33%	-45.70%	0.06	14.13	N/A	N/A	N/A
SGRY	SURGERY PARTNERS INC	$1.58B	-4.50%	-1.00%	2.83%	3.60%	2.91	1.87	23.10%	-2.40%	6.43%
HOWL	WEREWOLF THERAPEUTICS INC	$49.08M	-158.80%	-69.70%	-167.07%	-181.70%	1.80	1.62	N/A	N/A	N/A
EVMN	EVOMMUNE INC	$854.36M	-224.60%	-45.80%	-33.26%	-70.50%	0.09	8.57	100.00%	-529.80%	-529.77%
LPCN	LIPOCINE INC	$14.96M	-59.30%	-53.40%	-66.50%	-82.90%	0.18	6.68	100.00%	-487.10%	-487.04%
QTRX	QUANTERIX CORP	$177.90M	-35.20%	-26.20%	-32.64%	-50.00%	0.42	2.84	46.80%	-77.10%	-80.83%
ABOS	ACUMEN PHARMACEUTICALS INC	$194.97M	-111.30%	-75.70%	-126.16%	-94.10%	0.74	4.07	N/A	N/A	N/A
WHWK	WHITEHAWK THERAPEUTICS INC	$165.66M	-12.00%	-11.20%	-15.11%	-34.40%	0.11	10.26	89.40%	-288.30%	-288.26%
ACRS	ACLARIS THERAPEUTICS INC	$455.05M	-52.00%	-35.90%	-49.25%	-50.00%	0.56	3.36	6.90%	-829.60%	-829.58%
IBIO	IBIO INC	$68.40M	-71.30%	-57.90%	-41.99%	-149.60%	0.14	9.04	100.00%	-8,245.70%	-8,187.33%
SSII	SS INNOVATIONS INTERNATIONAL INC	$971.78M	-30.20%	-17.50%	-14.70%	-15.50%	0.94	1.86	46.00%	-28.50%	-16.60%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$2.17B	-1,169.30%	-43.10%	-49.74%	-37.30%	-18.45	2.48	83.80%	-85.40%	-84.84%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$136.92M	17.50%	13.90%	17.57%	19.40%	0.27	8.42	100.00%	32.00%	31.95%
OM	OUTSET MEDICAL INC	$73.43M	-55.00%	-28.90%	-29.53%	-22.70%	1.08	6.67	39.10%	-68.30%	-56.06%
MDXH	MDXHEALTH SA	$10.69M	N/A	-21.70%	-14.64%	-10.70%	-13.23	1.08	64.50%	-31.10%	-13.36%
JBIO	JADE BIOSCIENCES INC	$763.91M	-64.60%	-59.70%	-38.22%	-130.70%	0.05	21.09	N/A	N/A	N/A
MTVA	METAVIA INC	$6.41M	-202.20%	-91.90%	-236.95%	192.40%	1.09	1.93	N/A	N/A	N/A
GNLX	GENELUX CORP	$115.15M	-153.30%	-111.60%	-251.09%	-203.30%	0.65	2.43	N/A	N/A	N/A
AQST	AQUESTIVE THERAPEUTICS INC	$504.05M	N/A	-64.50%	-59.11%	-49.80%	-5.77	3.14	58.30%	-188.10%	-149.70%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$166.59M	-60.20%	-52.40%	-71.16%	-63.30%	0.19	8.61	N/A	N/A	N/A
SY	SO-YOUNG INTERNATIONAL INC	$287.62M	-14.40%	-9.20%	-12.95%	-21.60%	0.63	1.89	47.80%	-15.90%	-15.85%
PALI	PALISADE BIO INC	$313.52M	-47.80%	-43.00%	-12.93%	713.60%	0.04	28.95	N/A	N/A	N/A
EDIT	EDITAS MEDICINE INC	$261.32M	-523.30%	-74.20%	-115.62%	-188.10%	5.84	3.54	100.00%	-395.00%	-400.29%
FEED	ENVUE MEDICAL INC	$2.13M	-17.50%	-13.60%	-16.27%	433.50%	0.28	0.86	30.00%	-193.90%	-258.99%
CABA	CABALETTA BIO INC	$329.52M	-121.70%	-90.20%	-144.31%	-256.10%	0.47	2.77	N/A	N/A	N/A
CCRN	CROSS COUNTRY HEALTHCARE INC	$296.69M	-24.30%	-17.90%	-21.90%	-41.70%	0.39	3.78	20.30%	-9.00%	-7.71%
EDSA	EDESA BIOTECH INC	$51.26M	-55.80%	-52.50%	-56.01%	3,171.80%	0.05	16.82	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$35.44M	-242.00%	-90.40%	-150.13%	-264.40%	2.30	2.98	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$77.56M	-104.30%	-69.60%	-68.11%	770.80%	0.41	3.45	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$92.99M	-101.80%	-69.80%	-111.15%	-78.30%	0.71	3.41	82.80%	-574.50%	-564.55%
OCGN	OCUGEN INC	$586.94M	-2,626.40%	-123.80%	-306.05%	-162.30%	-4.58	1.06	100.00%	-1,537.40%	-1,419.85%
RPID	RAPID MICRO BIOSYSTEMS INC	$103.20M	-95.40%	-58.90%	-81.60%	-78.00%	1.25	3.31	3.10%	-140.30%	-136.94%
INBS	INTELLIGENT BIO SOLUTIONS INC	$4.41M	-197.90%	-99.20%	-89.49%	-470.70%	0.61	2.38	56.30%	-256.40%	-254.49%
KYTX	KYVERNA THERAPEUTICS INC	$536.10M	-81.40%	-66.60%	-62.49%	-107.10%	0.27	7.76	N/A	N/A	N/A
PTN	PALATIN TECHNOLOGIES INC	$31.40M	-5,515.10%	-114.80%	-82.96%	202.50%	0.56	2.76	100.00%	-107.40%	-107.32%
ATAI	ATAIBECKLEY INC	$1.38B	-389.70%	-287.70%	-244.61%	-421.50%	0.32	11.74	100.00%	-16,142.00%	-16,106.31%
NKTR	NEKTAR THERAPEUTICS	$2.21B	-508.80%	-80.00%	-81.53%	-72.60%	2.12	4.97	354.90%	-1,737.90%	-1,536.70%
DNA	GINKGO BIOWORKS HOLDINGS INC	$427.28M	-53.70%	-25.90%	-30.63%	-24.80%	1.20	4.92	72.40%	-183.80%	-184.30%
ACOG	ALPHA COGNITION INC	$130.21M	-48.90%	-37.60%	-29.28%	-851.60%	0.28	8.65	81.30%	-202.20%	-202.24%
LYEL	LYELL IMMUNOPHARMA INC	$450.04M	-90.50%	-70.20%	-94.43%	-93.30%	0.37	5.28	100.00%	-762,355.60%	-762,355.56%
EWTX	EDGEWISE THERAPEUTICS INC	$3.58B	-32.00%	-30.50%	-31.95%	-34.80%	0.06	19.85	N/A	N/A	N/A
SLDB	SOLID BIOSCIENCES INC	$736.95M	-73.30%	-60.20%	-87.67%	-107.70%	0.29	6.14	N/A	N/A	N/A
KYNB	KYNTRA BIO INC	$28.37M	-150.70%	122.30%	212.64%	160.20%	-3.83	3.39	91.40%	2,848.60%	2,983.25%
ALVO	ALVOTECH	$1.14B	-11.90%	2.00%	24.14%	12.80%	-6.23	1.89	60.00%	4.70%	48.49%
ABVX	ABIVAX SA	$9.30B	-147.50%	-88.30%	-41.91%	-845.00%	0.28	8.75	100.00%	-7,354.50%	-4,781.42%
NVCT	NUVECTIS PHARMA INC	$200.28M	-143.90%	-92.80%	-143.61%	243.20%	0.72	2.39	N/A	N/A	N/A
TENX	TENAX THERAPEUTICS INC	$258.22M	-51.80%	-49.50%	-54.19%	2,649.80%	0.07	14.57	N/A	N/A	N/A
OPK	OPKO HEALTH INC	$875.18M	-17.40%	-11.20%	-7.45%	-16.10%	0.52	3.97	33.90%	-37.20%	-21.90%
PMVP	PMV PHARMACEUTICALS INC	$71.46M	-59.10%	-54.20%	-76.00%	-88.10%	0.11	10.09	N/A	N/A	N/A
PHIO	PHIO PHARMACEUTICALS CORP	$14.87M	-66.60%	-60.30%	-43.17%	983.40%	0.07	16.03	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$3.74B	-29.40%	-26.00%	-21.59%	-33.50%	0.09	13.25	N/A	N/A	N/A
TAOX	TAO SYNERGIES INC	$42.59M	-195.40%	-146.60%	-119.63%	-293.70%	0.19	13.99	100.00%	-9,722.40%	-9,609.23%
DMAC	DIAMEDICA THERAPEUTICS INC	$349.16M	-77.60%	-69.40%	-58.21%	-90.70%	0.09	11.81	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$150.81M	-85.20%	-70.00%	-68.90%	-153.10%	0.19	6.84	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$112.19M	-933.60%	-295.30%	3,230.75%	929.30%	-8.30	0.88	N/A	N/A	N/A
ANIX	ANIXA BIOSCIENCES INC	$85.50M	-65.60%	-62.50%	-73.64%	-77.20%	0.09	12.18	N/A	N/A	N/A
CGEM	CULLINAN THERAPEUTICS INC	$873.39M	-46.30%	-43.40%	-53.55%	-55.90%	0.10	10.25	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$31.95M	N/A	-181.50%	587.27%	-66.00%	-1.47	0.83	74.50%	-10,887.40%	-8,241.90%
HURA	TUHURA BIOSCIENCES INC	$89.65M	-179.40%	-117.50%	-137.29%	-1,099.30%	0.31	0.78	N/A	N/A	N/A
PLRZ	POLYRIZON LTD	$19.43M	-25.40%	-24.70%	-29.77%	-73.60%	0.02	29.03	N/A	N/A	N/A
COYA	COYA THERAPEUTICS INC	$94.06M	-64.30%	-55.20%	-48.15%	1,779.30%	0.16	8.51	100.00%	-267.10%	-267.10%
SNGX	SOLIGENIX INC	$11.75M	-241.80%	-130.20%	-204.41%	432.30%	0.75	2.39	N/A	N/A	N/A
SGP	SPYGLASS PHARMA INC	$750.76M	N/A	-57.30%	-37.16%	-509.10%	-0.10	12.67	N/A	N/A	N/A
OCS	OCULIS HOLDING AG	$1.54B	-62.60%	-50.10%	-49.35%	-114.00%	0.20	5.96	100.00%	-8,253.30%	-8,199.34%
PSTV	PLUS THERAPEUTICS INC	$24.43M	N/A	-156.00%	-468.14%	331.30%	3.09	1.23	100.00%	-429.40%	-360.20%
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$5.12M	N/A	-1,468.10%	253.95%	659.30%	-1.21	0.17	-1.90%	-394,725.10%	-257,168.22%
ALDX	ALDEYRA THERAPEUTICS INC	$99.90M	-63.70%	-41.30%	-72.18%	-184.80%	0.63	2.58	N/A	N/A	N/A
CNTN	CANTON STRATEGIC HOLDINGS INC	$184.70M	-35.60%	-27.10%	-8.16%	-34.00%	0.31	5.29	N/A	N/A	N/A
RCKT	ROCKET PHARMACEUTICALS INC	$385.42M	-65.80%	-56.10%	-73.68%	-84.30%	0.19	6.38	N/A	N/A	N/A
KOD	KODIAK SCIENCES INC	$2.51B	-255.40%	-81.80%	-75.15%	-85.30%	1.23	4.72	N/A	N/A	N/A
ALT	ALTIMMUNE INC	$434.43M	-49.40%	-41.70%	-32.89%	-66.40%	0.25	18.55	100.00%	-214,861.00%	-212,531.71%
ANNX	ANNEXON INC	$882.61M	-102.20%	-77.60%	-87.98%	-169.40%	0.31	5.68	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	606	-0.01%	+3.43%	-0.16%	-29.10%	28.69x	4.77x	-38.36%	-14.24%	-8.58%	+63.52%	Strong Buy
Diagnostics & Research	55	+0.31%	+1.69%	-3.45%	+10.47%	20.41x	3.69x	-2.71%	+6.61%	+12.95%	+25.93%	Strong Buy
Drug Manufacturers - General	20	-1.34%	+2.11%	-6.55%	+20.55%	32.72x	7.01x	+10.22%	+12.41%	+21.10%	+19.20%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.19%	+0.83%	-6.28%	-27.18%	-196.18x	1.63x	+9.19%	+2.51%	+7.27%	+43.81%	Strong Buy
Healthcare Plans	10	+1.24%	+1.76%	-5.45%	-36.04%	22.78x	1.80x	+9.09%	+2.85%	+6.97%	+25.73%	Buy
Health Information Services	55	+0.55%	-0.27%	-8.49%	-80.30%	23.49x	2.80x	-7.72%	+2.33%	+4.64%	+61.04%	Buy
Medical Care Facilities	50	-0.22%	-1.38%	-10.26%	-42.38%	18.03x	5.29x	-68.62%	+7.35%	+19.11%	+25.02%	Buy
Medical Devices	137	-0.07%	-1.18%	-9.86%	-66.48%	23.94x	3.27x	+8.46%	+5.25%	+9.40%	+54.60%	Strong Buy
Medical Distribution	10	+1.45%	+2.26%	-10.46%	+25.96%	29.76x	317.88x	-99.39%	+3.30%	+23.34%	+14.03%	Strong Buy
Medical Instruments & Supplies	57	-0.61%	+0.07%	-7.92%	-10.20%	-490.95x	3.36x	+9.37%	+7.41%	+4.05%	+32.85%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 17 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock lose -5.68% over the past year, overperforming other healthcare stocks by 30 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 67.22% from Bioventus's current stock price of $8.97.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 8 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 52.75% over the past year, overperforming other healthcare stocks by 88 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 20.19% from Amneal Pharmaceuticals's current stock price of $12.48.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #3 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 32, which is 5 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 13.52% over the past year, overperforming other healthcare stocks by 49 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $10.00, an upside of 56.74% from Aveanna Healthcare Holdings's current stock price of $6.38.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 205.13%, which is 200 percentage points higher than the healthcare sector average of 4.92%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 24.18%, which is 19 percentage points higher than the healthcare sector average of 4.92%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.23%, which is 6 percentage points higher than the healthcare sector average of 4.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 162.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.05% in the last day, and up 1.62% over the last week. Lipocine was the among the top losers in the healthcare sector, dropping -77.84% yesterday.

Lipocine shares are trading lower after the company's LPCN 1154 missed its Phase 3 primary endpoint in postpartum depression.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 70 points higher than the healthcare sector average of 16. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -29.31% in the past year. It has overperformed other stocks in the healthcare sector by 6 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 145.83% in the past year. It has overperformed other stocks in the healthcare sector by 181 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -14.72% in the past year. It has overperformed other stocks in the healthcare sector by 21 percentage points.

Are healthcare stocks a good buy now?

58.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.05% over the next year.

5.73% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.7% of healthcare stocks are rated B (Buy), 50.93% are rated C (Hold), 23.91% are rated D (Sell), and 6.72% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is -8.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.